Skip to main content

Dana-Farber/Harvard Cancer Center

Dana-Farber/Harvard Cancer Center (DF/HCC) is a collaboration between academic institutions, world-renowned for its leadership in adult and pediatric cancer treatment and research. Dana-Farber Cancer Institute is a founding member of DF/HCC, established in Boston in 1947 under the leadership of Dr. Sidney Farber, the father of modern chemotherapy, and one of the first to become an NCI-Designated Comprehensive Cancer Center in 1973.

Focused equally on cancer research and care, DF/HCC’s mission is to provide expert, compassionate care to children and adults with cancer, while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases, and training the next generation of clinical and scientific leaders.

In addition to Dana-Farber Cancer Institute, the DF/HCC consortium includes six other Harvard-affiliated institutions, including Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Brigham and Women’s Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, and Massachusetts General Hospital. The member institutions combine their scientific strengths to accelerate research findings from the laboratory, clinical research trials, and studies of populations, enhancing patient care and the understanding of underlying causes of cancer.

Read more about the Dana-Farber/Harvard Cancer Center.

Dana-Farber Cancer Institute

Comp
Benjamin L Ebert, MD, PhD
President & CEO
450 Brookline Avenue
Mailstop: BP332A
Boston, MA 02115
(617) 632-2100

Senior Leaders

Senior Leader Title
Benjamin L Ebert, MD, PhD Director
Christopher Lathan, MD, MS, MPH Deputy Associate Director, Community Outreach and Engagement
David Avigan, MD Co-Associate Director, Clinical Science
David Ryan, MD Co-Associate Director, Clinical Science
Deborah Goff, PhD Associate Director, Administration
Erica Warner, ScD, MPH Deputy Associate Director, Membership
Jeffrey Meyerhardt, MD, MPH Associate Director, Clinical Trials
Jon Aster, MD, PhD Deputy Associate Director, Membership
K Vish Viswanath, PhD Associate Director, Community Outreach and Engagement
Karen Adelman, PhD Associate Director, Basic Science
Kathleen Burns, MD, PhD Associate Director, Shared Resources
Lee Nadler, MD Associate Director, Cancer Research
Training and Education
Lorelei Mucci, ScD, MPH Associate Director, Population Science
Nadine Tung, MD Associate Director, Membership
Ramesh Shivdasani, MD, PhD Deputy Director
Stephen Blacklow, MD, PhD Associate Director, Development
White Karen Burns, MS Deputy Associate Director, Community Outreach and Engagement

Research Programs

Research Program Program Leaders
Breast Cancer Leif Ellisen, MD, PhD; Elizabeth Mittendorf, MD, PhD; Sara Tolaney, MD, MPH
Cancer Care Delivery Research Nancy Keating, MD, MPH; Jennifer Temel, MD; Jennifer Mack, MD, MPH
Cancer Cell Biology Jeffrey Harper, PhD; Kornelia Polyak, MD, PhD; Raul Mostoslavsky, MD, PhD
Cancer Data Sciences Martin Aryee, PhD; Xihong Lin, PhD; Franziska Michor, PhD
Cancer Epidemiology Andrew Chan, MD, MPH; Brittany Charlton, ScD, MSc; Heather Eliassen, ScD
Cancer Genetics and Epigenetics Gad Getz, MSc, PhD; Cigall Kadoch, PhD; Eliezer Van Allen, MD
Cancer Immunology Arlene Sharpe, MD, PhD; Kai Wucherpfennig, MD, PhD
Cancer Risk, Prevention and Early Detection Lecia Sequist, MD, MPH; Sapna Syngal, MD, MPH; Guillermo Tearney, MD, PhD
Developmental Therapeutics Keith Flaherty, MD; Geoffrey Shapiro, MD, PhD
Gastrointestinal Malignancies Ryan Corcoran, MD, PhD; Brian Wolpin, MD, PhD
Gynecologic Cancers Cesar Castro, MD, MMsc; Alan DAndrea, MD; Ursula Matulonis, MD
Kidney Cancer David McDermott, MD; Toni Choueiri, MD; Sabina Signoretti, MD
Leukemia Timothy Graubert, MD; Andrew Lane, MD, PhD; Jacalyn Rosenblatt, MD
Lung Cancer Justin Gainor, MD; David Barbie, MD; Carla Kim, PhD
Lymphoma and Myeloma Matthew Davids, MD, MMsc; Irene Ghobrial, MD
Melanoma David Fisher, MD, PhD; Frank Hodi, MD
Neuro-Oncology Tracy Batchelor, MD, MPH; Daphne Haas-Kogan, MD; Scott Plotkin, MD, PhD; Mario Suva, MD, PhD
Prostate Cancer Steven Balk, MD, PhD; Matthew Smith, MD, PhD; Mary-Ellen Taplin, MD

Shared Resources

Category Resource Directors
Cat 1: Laboratory Science Cancer Proteomics Towia Libermann, PhD
Cat 1: Laboratory Science Mouse Engineering Arlene Sharpe, MD, PhD
Cat 3: Epidemiology, Cancer Control Health Communication Vish Viswanath, PhD
Cat 3: Epidemiology, Cancer Control Survey and Qualitative Methods Wendy London, PhD
Cat 4: Clinical Research Cell Manipulation Jerome Ritz, MD
Cat 4: Clinical Research Research Pharmacy Sylvia Bartel, RPh, MPH
Cat 4: Clinical Research Rodent Histopathology Peter Howley, MD
Cat 4: Clinical Research Spatial Technologies Unit (Developing) Ioannis Vlachos, PhD
Cat 4: Clinical Research Specialized Histopathology Services Jon Aster, MD, PhD; Anat Stemmer-Rachamimov, MD
Cat 4: Clinical Research Tissue Microarray and Imaging Sabina Signoretti, MD
Cat 4: Clinical Research Tumor Imaging Metrics Gordon Harris, PhD; Annick Van Den Abbeele, MD
Cat 6: Biostatistics Biostatistics Paul Catalano, ScD; Nabihah Tayob, PhD
Cat 7: Informatics Bioinformatics Training Shannan Ho Sui, PhD
Last Updated
December 4, 2025